Sudden death in patients without structural heart disease

Journal of the American College of Cardiology

Volumn 43, Issue 7, 2004, Pages 1137-1144

  Wever, Eric F D ^a,b   De Medina, Etienne O Robles ^c  

^a Department of Cardio Thoracic Surgery   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atrioventricular; AV; Electrophysiologic study; EPS; ICD; Idiopathic Ventricular Fibrillation Registry of the United States of America; Implantable cardioverter defibrillator; IVF US; Long QT syndrome(s); LQTS; SCD; Sudden cardiac death; U CARE

Indexed keywords

AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ERGOMETRINE; FLECAINIDE; PROCAINAMIDE; VERAPAMIL;

ACUTE HEART INFARCTION; BRUGADA SYNDROME; CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATION; ECG ABNORMALITY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; FOLLOW UP; GENETIC PROCEDURES; HEART ARREST; HEART DISEASE; HEART FUNCTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; IMAGING SYSTEM; LONG QT SYNDROME; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGICAL STIMULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; RESUSCITATION; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SYMPATHECTOMY; TORSADE DES POINTES; TREATMENT FAILURE; TREATMENT OUTCOME; WOLFF PARKINSON WHITE SYNDROME;

DEATH, SUDDEN, CARDIAC; HEART DISEASES; HUMANS; INCIDENCE; REVIEW LITERATURE;

EID: 1842425821     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.10.053     Document Type: Review

References (58)

1. Wever E.F.D., Hauer R.N.W., Oomen A., Peters R.H.J., Bakker P.F.A., Robles de Medina E.O. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation. 88:1993;1021-1029.
2. Zipes D.P., Wellens H.J.J. Sudden cardiac death. Circulation. 98:1998;2334-2351.
3. Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Circulation. 95:1997;265-267.
4. Chugh S.S., Kelly K.L., Titus J.L. Sudden cardiac death with apparently normal heart. Circulation. 102:2000;649-654.
5. Chugh S.S. Sudden cardiac death with apparently normal heart Clinical implications of progress in pathophysiology. Card Electrophysiol Rev. 5:2001;394-402.
6. Weaver W.D., Cobb L.A., Hallstrom A.P., Fahrenbruch C., Copass M.K., Ray R. Factors influencing survival after out-of-hospital cardiac arrest. J Am Coll Cardiol. 7:1986;752-757.
7. Wilber D.J., Garan H., Finkelstein D., et al. Out-of-hospital cardiac arrest Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 318:1988;19-24.
8. Myerburg R.J., Castellanos A. Cardiac arrest and sudden death. Braunwald E. Heart Disease A textbook of cardiovascular medicine. 1997;742-779 WB Saunders, Philadelphia, PA.
9. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785.
10. Marian A.J., Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy Genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 9:1998;88-99.
11. Tomaselli G.F., Beuckelmann D.J., Calkins H.G., et al. Sudden cardiac death in heart failure The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
12. Corrado D., Basso C., Thiene G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia A multicenter study. J Am Coll Cardiol. 30:1997;1512-1520.
13. Blake L.M., Scheinmann M.M., Higgins C.B. MR features of arrhythmogenic right ventricular dysplasia. Am J Roentgenol. 162:1994;809-812.
14. Philips M.P., Robinowitz M., Higgins J.R., Boran K.J., Reed T., Virmani R. Sudden cardiac death in Air Force recruits. JAMA. 256:1986;2696-2699.
15. Haugen R.K. The café coronary Sudden deaths in restaurants. JAMA. 186:1963;142-143.
16. Ettinger P.O., Wu C.F., De La Cruz C., Weisse A.B., Ahmed S.S., Regan T.J. Arrhythmias and the "holiday heart" Alcohol-associated cardiac rhythm disorders. Am Heart J. 95:1978;555-562.
17. Wannamethee G., Shaper A.G. Alcohol and sudden cardiac death. Br Heart J. 68:1992;443-448.
18. Benatar S.R. Fatal asthma. N Engl J Med. 314:1986;1986-1994.
19. Morgan M. Amniotic fluid embolism. Anaesthesia. 34:1979;20-32.
20. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 321:1989;406-412.
21. Akhtar M., Breithardt G., Camm A.J., et al. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. CAST and beyond Implications of the cardiac arrhythmia suppression trial. Circulation. 81:1990;1123-1127.
22. Bhandari A.K., Scheinman M.M. The long QT syndrome. Modern Concepts Cardiovasc Dis. 54:1985;45.
23. Myerburg R.J., Kessler K.M., Mallon S.M., et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med. 326:1992;1451-1455.
24. Wolff L., Parkinson J., White P.D. Bundle-branch block with short P-R interval in young healthy people prone to paroxysmal tachycardia. Am Heart J. 5:1930;685.
25. Schwartz P.J., Periti M., Malliani A. The long QT syndrome. Am Heart J. 89:1975;378-390.
26. Klein G.J., Bashore T.M., Sellers T.D., Pritchett E.L.C., Smith W.M., Gallagher J.J. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 301:1979;1080-1085.
27. Packer D.L., Prystowsky E.N. Wolff-Parkinson-White syndrome Further progress in evaluation and treatment. Zipes D.P., Rowlands D.J. Progress in Cardiology 1/1. 1988;147-187 Lea & Febiger, Philadelphia, PA.
28. Bromberg B.I., Lindsay B.D., Cain M.E., Cox J.L. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 27:1996;690-695.
29. Morady F. Radio-frequency catheter ablation as treatment for cardiac arrhythmias. N Engl J Med. 340:1999;534-544.
30. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome An update. Circulation. 88:1993;782-784.
31. Priori S.G., Napolitano C., Diehl L., Schwartz P.J. Dispersion of the QT interval A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 89:1994;1681-1689.
32. Leenhardt A., Glaser E., Burguera M., Nurnberg M., Maison-Blanche P., Coumel P. Short-coupled variant of torsades de pointes A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation. 89:1994;206-215.
33. 1). J Am Coll Cardiol. 33:1999;327-332.
34. Romano C., Genrme G., Pongiglione R. Aritmie cardiache rare dell'eta pediatrica. Clin Pediatr. 45:1963;658-683.
35. Ward O.C. A new familial cardiac syndrome in children. J Ir Med Assoc. 54:1964;103-106.
36. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 54:1957;59-68.
37. Splawski I., Shen J., Timothy K.W., et al. Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 102:2000;1178-1185.
38. Schwartz P.J., Priori S.G., Napolitano C. Long QT syndrome. Zipes D.P., Jalife J. Cardiac Electrophysiology From cell to bedside. 2000;597-615 WB Saunders, Orlando, FL.
39. Priori S.G., Napolitano C., Schwartz P.J., Bloise R., Crotti L., Ronchetti E. The elusive link between LQT3 and Brugada syndrome The role of flecainide challenge. Circulation. 102:2000;945-947.
40. Priori S.G., Napolitano C., Giordano U., Collisani G., Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet. 355:2000;808-809.
41. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 20:1992;1391-1396.
42. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol. 8:1997;325-331.
43. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature. 392:1998;293-296.
44. Alings M., Wilde A.A.M. Brugada syndrome Clinical data and suggested pathophysiological mechanism. Circulation. 99:1999;666-673.
45. Brugada R., Brugada J., Antzelevitch C., et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 101:2000;510-515.
46. + channel mutation causing both long-QT and Brugada syndromes. Circ Res. 85:1999;1206-1213.
47. Boersma L.V.A., Jaarsma W., Jessurun E.R.J., Van Hemel N.M., Wever E.F.D. Brugada syndrome A case report of monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 24:2001;112-115.
48. Schott J.J., Alshinawa C., Kyndt F., et al. Cardiac conduction defects associated with mutations in SCN5A. Nat Genet. 23:1999;20-21.
49. Munger R.G., Booton E.A. Thiamine and sudden death in sleep of South-East Asian refugees. Lancet. 335:1990;1154-1155.
50. Nimmannit S., Malasit P., Chaovakul V., Susaengrat W., Nilwarankur S. Potassium and sudden unexplained nocturnal death. Lancet. 336:1990;116-117.
51. Nademanee K., Veerakul G., Nimmannit S., et al. Arrhythmogenic marker for the sudden, unexplained death syndrome in Thai men. Circulation. 96:1997;2595-2600.
52. Coumel P., Fidelle J., Lucet V., Attuel P., Bouvrain Y. Catecholamine-induced severe ventricular arrhythmias with Adam-Stokes syndrome in children Report of four cases. Br Heart J. 40:(Suppl):1978;28-37.
53. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie cathecholaminergic polymorphic ventricular tachycardia. Circulation. 103:2001;196-200.
54. Brugada P., Lemery R., Talajic M., Della Bella P., Wellens H.J.J. Treatment of patients with ventricular tachycardia or ventricular fibrillation First lessons from the "parallel study" Brugada P., Wellens H.J.J. Cardiac Arrhythmias Where to go from here? 1987;457-470 Futura, Mount Kisco, NY.
55. Peters R.H.J., Wever E.F.D., Hauer R.N.W., Robles de Medina E.O. Low prevalence of coronary artery spasm in patients with normal coronary angiograms and unexplained ventricular fibrillation. Eur Heart J. 19:1998;1070-1074.
56. Belhassen B., Shapira I., Shoshani D., Parades A., Miller H., Laniado S. Idiopathic ventricular fibrillation Inducibility and beneficial effect of class I antiarrhythmic agents. Circulation. 75:1987;809-816.
57. Jackman W.M., Friday K.J., Anderson J.L., Aliot E.M., Clark M., Lazarra R. The long QT syndromes A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 31:1988;115-172.
58. Prystowsky E.N., Miles W.M., Evans J.J., et al. Induction of ventricular tachycardia during programmed electrical stimulation Analysis of pacing methods. Circulation. 73:(Suppl II):1986;II32-II38.